Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion

Shigeta Moriya, Mitsuhiro Hasegawa, Joji Inamasu, Hirotaka Kogame, Yuichi Hirose, Ryo Higashi, Makoto Ito, Fumihiro Imai

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND: Pregabalin (PGB), a drug used for treating neuropathic pain, has immune-modulating property that may have therapeutic implications. Suppression of microglial activation and improvement in functional recovery was observed in experimental spinal cord injury after PGB administration. An experimental study was conducted to evaluate whether PGB could afford neuroprotection in a rat model of intracisternal facial nerve avulsion. METHODS: Twenty-eight male Wistar rats (250-300 g) were dichotomized into two groups: a PGB group (N.=14) and a control group (N.=14). The PGB group received a total of 4 intraperitoneal PGB injections (30 mg/kg, 15 minutes preoperatively and 4, 24, and 48 hours postoperatively), and the control group underwent intraperitoneal saline injection. Intracisternal facial nerve avulsion was created by tangential pull-out of the nerve surgically exposed at the stylomastoid foramen. In both groups, the brainstem containing the facial motor nuclei neurons was thin-sliced and stained with cresyl violet, and the number of viable neurons in the facial motor nuclei on days 14 and 28 was counted under microscope. RESULTS: The total viable neuron count was significantly greater in the PGB group than in the Control group both on day 14 (271.4±14.9 vs. 196.2±22.2, P<0.01) and day 28 (160.2±21.6 vs. 102.6±13.4, P<0.01). Furthermore, CD11b/c immunostaining on days 3 and 8 showed that CD11b/c-positive cells, suggestive of activated microglia, were observed only in the control group. CONCLUSIONS: Better neuronal survival by PGB administration may be beneficial and clinically relevant when surgical reconstruction of the facial nerve, such as hypoglossal-facial nerve anastomosis, is considered.

Original languageEnglish
Pages (from-to)495-503
Number of pages9
JournalJournal of Neurosurgical Sciences
Volume61
Issue number5
DOIs
Publication statusPublished - 01-10-2017

Fingerprint

Facial Nerve Injuries
Neuroprotective Agents
Control Groups
Facial Nerve
Intraperitoneal Injections
Hypoglossal Nerve
Neurons
Pregabalin
Microglia
Neuralgia
Motor Neurons
Spinal Cord Injuries
Brain Stem
Wistar Rats

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Moriya, Shigeta ; Hasegawa, Mitsuhiro ; Inamasu, Joji ; Kogame, Hirotaka ; Hirose, Yuichi ; Higashi, Ryo ; Ito, Makoto ; Imai, Fumihiro. / Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion. In: Journal of Neurosurgical Sciences. 2017 ; Vol. 61, No. 5. pp. 495-503.
@article{0a2e44ca99ee4543b7cc75bf86f559d7,
title = "Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion",
abstract = "BACKGROUND: Pregabalin (PGB), a drug used for treating neuropathic pain, has immune-modulating property that may have therapeutic implications. Suppression of microglial activation and improvement in functional recovery was observed in experimental spinal cord injury after PGB administration. An experimental study was conducted to evaluate whether PGB could afford neuroprotection in a rat model of intracisternal facial nerve avulsion. METHODS: Twenty-eight male Wistar rats (250-300 g) were dichotomized into two groups: a PGB group (N.=14) and a control group (N.=14). The PGB group received a total of 4 intraperitoneal PGB injections (30 mg/kg, 15 minutes preoperatively and 4, 24, and 48 hours postoperatively), and the control group underwent intraperitoneal saline injection. Intracisternal facial nerve avulsion was created by tangential pull-out of the nerve surgically exposed at the stylomastoid foramen. In both groups, the brainstem containing the facial motor nuclei neurons was thin-sliced and stained with cresyl violet, and the number of viable neurons in the facial motor nuclei on days 14 and 28 was counted under microscope. RESULTS: The total viable neuron count was significantly greater in the PGB group than in the Control group both on day 14 (271.4±14.9 vs. 196.2±22.2, P<0.01) and day 28 (160.2±21.6 vs. 102.6±13.4, P<0.01). Furthermore, CD11b/c immunostaining on days 3 and 8 showed that CD11b/c-positive cells, suggestive of activated microglia, were observed only in the control group. CONCLUSIONS: Better neuronal survival by PGB administration may be beneficial and clinically relevant when surgical reconstruction of the facial nerve, such as hypoglossal-facial nerve anastomosis, is considered.",
author = "Shigeta Moriya and Mitsuhiro Hasegawa and Joji Inamasu and Hirotaka Kogame and Yuichi Hirose and Ryo Higashi and Makoto Ito and Fumihiro Imai",
year = "2017",
month = "10",
day = "1",
doi = "10.23736/S0390-5616.16.03263-X",
language = "English",
volume = "61",
pages = "495--503",
journal = "Journal of Neurosurgical Sciences",
issn = "0390-5616",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "5",

}

Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion. / Moriya, Shigeta; Hasegawa, Mitsuhiro; Inamasu, Joji; Kogame, Hirotaka; Hirose, Yuichi; Higashi, Ryo; Ito, Makoto; Imai, Fumihiro.

In: Journal of Neurosurgical Sciences, Vol. 61, No. 5, 01.10.2017, p. 495-503.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion

AU - Moriya, Shigeta

AU - Hasegawa, Mitsuhiro

AU - Inamasu, Joji

AU - Kogame, Hirotaka

AU - Hirose, Yuichi

AU - Higashi, Ryo

AU - Ito, Makoto

AU - Imai, Fumihiro

PY - 2017/10/1

Y1 - 2017/10/1

N2 - BACKGROUND: Pregabalin (PGB), a drug used for treating neuropathic pain, has immune-modulating property that may have therapeutic implications. Suppression of microglial activation and improvement in functional recovery was observed in experimental spinal cord injury after PGB administration. An experimental study was conducted to evaluate whether PGB could afford neuroprotection in a rat model of intracisternal facial nerve avulsion. METHODS: Twenty-eight male Wistar rats (250-300 g) were dichotomized into two groups: a PGB group (N.=14) and a control group (N.=14). The PGB group received a total of 4 intraperitoneal PGB injections (30 mg/kg, 15 minutes preoperatively and 4, 24, and 48 hours postoperatively), and the control group underwent intraperitoneal saline injection. Intracisternal facial nerve avulsion was created by tangential pull-out of the nerve surgically exposed at the stylomastoid foramen. In both groups, the brainstem containing the facial motor nuclei neurons was thin-sliced and stained with cresyl violet, and the number of viable neurons in the facial motor nuclei on days 14 and 28 was counted under microscope. RESULTS: The total viable neuron count was significantly greater in the PGB group than in the Control group both on day 14 (271.4±14.9 vs. 196.2±22.2, P<0.01) and day 28 (160.2±21.6 vs. 102.6±13.4, P<0.01). Furthermore, CD11b/c immunostaining on days 3 and 8 showed that CD11b/c-positive cells, suggestive of activated microglia, were observed only in the control group. CONCLUSIONS: Better neuronal survival by PGB administration may be beneficial and clinically relevant when surgical reconstruction of the facial nerve, such as hypoglossal-facial nerve anastomosis, is considered.

AB - BACKGROUND: Pregabalin (PGB), a drug used for treating neuropathic pain, has immune-modulating property that may have therapeutic implications. Suppression of microglial activation and improvement in functional recovery was observed in experimental spinal cord injury after PGB administration. An experimental study was conducted to evaluate whether PGB could afford neuroprotection in a rat model of intracisternal facial nerve avulsion. METHODS: Twenty-eight male Wistar rats (250-300 g) were dichotomized into two groups: a PGB group (N.=14) and a control group (N.=14). The PGB group received a total of 4 intraperitoneal PGB injections (30 mg/kg, 15 minutes preoperatively and 4, 24, and 48 hours postoperatively), and the control group underwent intraperitoneal saline injection. Intracisternal facial nerve avulsion was created by tangential pull-out of the nerve surgically exposed at the stylomastoid foramen. In both groups, the brainstem containing the facial motor nuclei neurons was thin-sliced and stained with cresyl violet, and the number of viable neurons in the facial motor nuclei on days 14 and 28 was counted under microscope. RESULTS: The total viable neuron count was significantly greater in the PGB group than in the Control group both on day 14 (271.4±14.9 vs. 196.2±22.2, P<0.01) and day 28 (160.2±21.6 vs. 102.6±13.4, P<0.01). Furthermore, CD11b/c immunostaining on days 3 and 8 showed that CD11b/c-positive cells, suggestive of activated microglia, were observed only in the control group. CONCLUSIONS: Better neuronal survival by PGB administration may be beneficial and clinically relevant when surgical reconstruction of the facial nerve, such as hypoglossal-facial nerve anastomosis, is considered.

UR - http://www.scopus.com/inward/record.url?scp=85026315745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026315745&partnerID=8YFLogxK

U2 - 10.23736/S0390-5616.16.03263-X

DO - 10.23736/S0390-5616.16.03263-X

M3 - Article

C2 - 25780867

AN - SCOPUS:85026315745

VL - 61

SP - 495

EP - 503

JO - Journal of Neurosurgical Sciences

JF - Journal of Neurosurgical Sciences

SN - 0390-5616

IS - 5

ER -